Among these, CpG sites associated with ZNF667, TEAD1, HDAC4, MSI2, and CCM2 were predominantly hypermethylated, while malignant tumors overall exhibited lower methylation levels compared to the benign group. The gene discussed is MSI2; the disease is cancer.